Onseget (Ondansetron) is indicated for the treatment of:

Adults

Prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of post-operative nausea and vomiting.

Pediatric Population

Management of chemotherapy-induced nausea and vomiting in children aged ≥ 6 months, and for the prevention and treatment of post-operative nausea and vomiting in Children aged ≥1 month.